Mina Awad Pharm D, R Ph, MBA
About Mina Awad Pharm D, R Ph, MBA
Mina Awad Pharm D, R Ph, MBA is the Director of Worldwide Medical Affairs and the Multiple Myeloma and Cellular Therapy Evidence Generation Lead at Bristol Myers Squibb. He has over six years of experience in the biopharma industry and holds advanced degrees in pharmacy and business administration.
Company
Currently serving as the Director of Worldwide Medical Affairs for Multiple Myeloma and Cellular Therapy Evidence Generation, Mina Awad works at Bristol Myers Squibb. This global biopharmaceutical company focuses on discovering, developing, and delivering innovative medicines for serious diseases.
Title
As Director of Worldwide Medical Affairs for Multiple Myeloma and Cellular Therapy Evidence Generation at Bristol Myers Squibb, Mina Awad leads evidence generation efforts aimed at advancing treatment strategies for critical conditions.
Education and Expertise
Mina Awad holds a Doctor of Pharmacy (Pharm.D.) degree from St. John's University, specializing in Pharmacy, Pharmaceutical Sciences, and Administration. Additionally, Awad has earned a Master of Business Administration from Rutgers Business School, focusing on Strategy and Leadership, and has completed a post-doctoral fellowship at Rutgers University, becoming a Rutgers University Certified Industry Fellow (RUCIF).
Background
Mina Awad has over six years of experience in the biopharma industry, particularly in medical affairs. Awad has held various roles at Bristol Myers Squibb, including Senior Medical Science Liaison for Cellular Therapy from 2020 to 2023 and Associate Director, Worldwide Medical Lead for GU/GBM Oncology from 2019 to 2020. Previously, Awad worked at Rutgers University as an Adjunct Professor from 2017 to 2019 and at RITE AID as a Rite Aid Pharmacy from 2012 to 2017.
Achievements
Mina Awad has made significant contributions to the biopharma industry, particularly through leading evidence generation efforts for multiple myeloma and cellular therapy at Bristol Myers Squibb. Awad is skilled in collaborative problem solving and indication launch planning, reflecting a strong background in strategy development within the medical affairs sector.